(Q33490385)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7850920%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

A pharmacologically guided phase I study of carboplatin in combination with methotrexate and vinblastine in advanced urothelial cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7850920%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7850920%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

author name string

C Chevreau

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7850920%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

V Brunner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7850920%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

M Martinez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7850920%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

G Houin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7850920%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

R Bugat

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7850920%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

P Canal

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7850920%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

publication date

1 January 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7850920%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

27 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7850920%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7850920%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7850920%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

391-396

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7850920%20AND%20SRC:MED&resulttype=core&format=json

Carboplatin, methotrexate, and vinblastine in patients with bladder cancer who were ineligible for cisplatin-based chemotherapy

27 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS002800050252

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050252

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050252

Pharmacologic-based dosing of carboplatin: a better method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050252

Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050252

Carboplatin plus ifosfamide as salvage treatment of epithelial ovarian cancer: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050252

Impact of cyclophosphamide on relationships between carboplatin exposure and response or toxicity when used in the treatment of advanced ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050252

Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050252

Clinical Pharmacokinetics of Carboplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050252

Carboplatin. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050252

Carboplatin (NSC-241-240): an active platinum analog for the treatment of squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050252

Carboplatin, Methotrexate and Vinblastin (Carbo-MV) for Advanced Urothelial Cancer A Phase II Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050252

Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050252

Dose-toxicity relationship of carboplatin in combination with cyclophosphamide in ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050252

A phase II study of carboplatin in metastatic transitional cell carcinoma of the bladder (a report of the Medical Research Council Working Party on Urological Cancer, Subgroup in Advanced Bladder Cancer)

21 January 2018

1 reference

12 December 2020

Glomerular filtration rate measurement in man by the single injection methods using 51Cr-EDTA

1 reference

12 December 2020

Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum(II) analogue diamminecyclobutanedicarboxylatoplatinum

1 reference

12 December 2020

Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function

1 reference

12 December 2020